Cardiol Therapeutics Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Net Income	-33.82	-36.68	-28.13	-30.93	-31.64	Upgrade
Depreciation & Amortization	0.1	0.37	0.25	0.22	0.22	Upgrade
Asset Writedown & Restructuring Costs	-	-	-	1.36	0.08	Upgrade
Stock-Based Compensation	10.7	14.28	4.17	5.54	12.61	Upgrade
Other Operating Activities	-0.11	-2.1	-0.93	-9.15	-4.89	Upgrade
Change in Accounts Receivable	0.04	0.04	0.07	-0.14	-0.06	Upgrade
Change in Inventory	-	-	-	-	0.02	Upgrade
Change in Accounts Payable	0.26	-1.06	-1.29	4.47	2.39	Upgrade
Change in Other Net Operating Assets	-1.04	0.09	0.68	1.42	-2.27	Upgrade
Operating Cash Flow	-23.85	-25.06	-25.18	-27.22	-23.54	Upgrade
Capital Expenditures	-0.02	-0.02	-0.06	-0.07	-0.01	Upgrade
Investing Cash Flow	-0.02	-0.02	-0.06	-0.07	-0.01	Upgrade
Long-Term Debt Repaid	-0.06	-0.04	-0.06	-0.05	-0.05	Upgrade
Net Debt Issued (Repaid)	-0.06	-0.04	-0.06	-0.05	-0.05	Upgrade
Issuance of Common Stock	16.07	21.53	-	-	98.72	Upgrade
Other Financing Activities	-0.48	-2.65	-	-	-5.23	Upgrade
Financing Cash Flow	15.54	18.84	-0.06	-0.05	93.44	Upgrade
Foreign Exchange Rate Adjustments	-0.82	1.89	0.76	2.92	-0.01	Upgrade
Net Cash Flow	-9.16	-4.35	-24.54	-24.43	69.87	Upgrade
Free Cash Flow	-23.88	-25.08	-25.24	-27.3	-23.55	Upgrade
Free Cash Flow Margin	-	-	-	-	-29904.22%	Upgrade
Free Cash Flow Per Share	-0.28	-0.35	-0.39	-0.44	-0.55	Upgrade
Levered Free Cash Flow	-13.03	-11.71	-14.99	-20.64	-4.61	Upgrade
Unlevered Free Cash Flow	-13.03	-11.71	-14.99	-20.64	-4.61	Upgrade
Change in Working Capital	-0.73	-0.93	-0.55	5.75	0.08	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.